Method and computation entity for performing computation of a function over encrypted data
US-12335404-B2 · Jun 17, 2025 · US
This page is not indexed by search engines while we improve data quality.
NEC Laboratories Europe GmbH — Cross-Sectional Technologies
NEC Laboratories Europe GmbH holds 13 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | NEC Laboratories Europe GmbH |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 13 |
| Recent patents in slice | 5 |
| First year | 2019 |
| Last year | 2025 |
Representative patents
Notable publications linking NEC Laboratories Europe GmbH to Cross-Sectional Technologies.
Sars-cov-2 vaccines
US-2024408193-A1 · Dec 12, 2024 · US
Method and system for predicting a phenotypic feature of a host based on a microbiome of the host
US-2024212789-A1 · Jun 27, 2024 · US
Paging for delay tolerant mobile terminals and applications
US-11997640-B2 · May 28, 2024 · US
Method and computation entity for performing computation of a function over encrypted data
US-2023269089-A1 · Aug 24, 2023 · US
Recent filings
Latest patents from NEC Laboratories Europe GmbH in Cross-Sectional Technologies.
Method and computation entity for performing computation of a function over encrypted data
US-12335404-B2 · Jun 17, 2025 · US
Sars-cov-2 vaccines
US-2024408193-A1 · Dec 12, 2024 · US
Method and system for predicting a phenotypic feature of a host based on a microbiome of the host
US-2024212789-A1 · Jun 27, 2024 · US
Paging for delay tolerant mobile terminals and applications
US-11997640-B2 · May 28, 2024 · US
Method and computation entity for performing computation of a function over encrypted data
US-2023269089-A1 · Aug 24, 2023 · US
Related pages
Navigate to parent entity pages.